Hepcdac (Daklinza) Daclatasvir 60mg

DAKLINZA

New product

$79.00

$112.00 tax excl.

-$33.00

$79.00 per 28 Tablets

Indications & Dosage

HepcdacDaklinzaDaclatasvir 60mg, is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.

Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.

Hepcdac’s brand name is Daklinza by Bristol-Myers Squibb. Hepcdac is a generic oncologic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.

Additional Info

Package Quantity28
WarningsDon't take the drug without consulting a qualified doctor or physician
Suggested useFollow the doctor's advice
Delivery & Returns10-20 days

FDA Prescribing Info

Upload Prescription

After saving your customized product, remember to add it to your cart.
Allowed file formats are: GIF, JPG, PNG

Pictures

loader

* required fields

Reviews

Grade 
2018-01-16 04:55:56
Very Excited

I take the genric Deklenza and Savodi together once a day and genotype 3A. I've had a few side effects that's listed but nothing that I can't deal with. The most Bothersome side effects for me is it feels like my insides are slightly burning. Three weeks after taking these medications together my RNA came back less than 15 so I'm completing this course I'm very excited.

    Write your review!

    Write a review

    Hepcdac (Daklinza) Daclatasvir 60mg

    Hepcdac (Daklinza) Daclatasvir 60mg

    HepcdacDaklinzaDaclatasvir 60mg


    Accessories

    30 other products in the same category: